Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
myo-inositol + zinc
- Development stage
- Unknown
- Lead developer
- Azienda Ospedaliero-Universitaria Maggiore della Carità
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
This research intervention is a combination of **myo-inositol** and **zinc**, supplemented with galacto-oligosaccharides (GOS) derived from *Pisum sativum*. It is being investigated by the **Azienda Ospedaliero Universitaria Maggiore della Carita** for the treatment of pediatric obesity and insulin resistance. Myo-inositol acts as a second messenger in the insulin intracellular pathway, exhibiting insulin-mimetic properties that improve insulin sensitivity across various tissues. Zinc plays a critical role in insulin action, carbohydrate metabolism, and lipid profile regulation, while also serving as a component of key antioxidant enzymes. The combination is hypothesized to represent a valid therapeutic strategy in addition to standard dietary approaches for improving metabolic parameters in children and adolescents.
- Other names
- Zinc and Myo-inositolMyoinositol and ZincZinc and Myo-inositol in Paediatric Obesity
02
Targets
Misfolded SOD1
Beyond the preview
Go deeper on myo-inositol + zinc.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on myo-inositol + zinc.